Occupational Therapists in Port Orange, FL Accepting Medicare

168 Occupational Therapists found. Showing 161 - 168

Katie Ginader Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 5535 S Williamson Blvd Ste 774, Port Orange, FL 32128 Phone: 800-330-7711

Mylinh Nguyen Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 5535 S Williamson Blvd, Suite 774, Port Orange, FL 32128 Phone: 888-265-2680

Daytona Beach Hand Clinic Inc Occupational Therapist Medicare: Medicare Enrolled Practice Location: 3635 S Clyde Morris Blvd, St. 300, Port Orange, FL 32129 Phone: 386-258-8080    Fax: 386-258-8177

Alfonso Robinson Jr. Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 5535 S Williamson Blvd Ste 774, Port Orange, FL 32128 Phone: 888-265-2680

Josh Dowd Occupational Therapist Medicare: Accepting Medicare Assignments Practice Location: 5535 S Williamson Blvd Ste 774, Port Orange, FL 32128 Phone: 888-265-2680

Brittany Kramer Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 5535 S Williamson Blvd, Suite #774, Port Orange, FL 32128 Phone: 800-330-7711

Amanda Kimbler Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 5535 S Williamson Blvd, Suite 774, Port Orange, FL 32128 Phone: 800-330-7711

Tricia Hart Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 5535 S Williamson Blvd, Suite 774, Port Orange, FL 32128 Phone: 888-265-2680

News Archive

Every hour, every day a child is taken to a hospital as injuries surge 22 percent

High chairs and booster seats are commonly used to help make feeding young children easier. Although most parents assume these products are safe, millions have been recalled in recent years, and injuries associated with their use continue to occur.

Drug that spurs cancer cells to self-destruct is on road to human clinical trials

Thanks to a new $2 million investment, a drug that spurs cancer cells to self-destruct while sparing healthy cells is on the road to human clinical trials. The compound, known as PAC-1, has so far proven safe and has promising anti-cancer effects in cell culture, in mouse models of cancer and in pet dogs with spontaneously occurring lymphomas and osteosarcomas.

BioLineRx starts enrollment in Phase I/II trial of BL-8020 for treatment of HCV

BioLineRx, a biopharmaceutical development company, announced today enrollment of the first patient in a Phase I/II trial for BL-8020, an orally available, interferon-free treatment for the Hepatitis C virus.

Nature's Sunshine Products re-listed on the NASDAQ Capital Market

Nature's Sunshine Products, Inc., a leading manufacturer and marketer of encapsulated herbs and vitamins, and a publicly traded company since 1978, announced today that its common stock began trading on The NASDAQ Capital Market on Monday, October 12, 2009, under the symbol NATR.

Study uncovers new way to identify driver genes important for cancer progression

Until now, researchers believed recurrent mutations (hotspot mutations) in cancer tumors were the important mutations (driver mutations) that promoted cancer progression.

Read more Medical News

› Verified 3 days ago

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9(current)